ANALYSIS OF THE DNA-BINDING AND ACTIVATION PROPERTIES OF THE HUMAN TRANSCRIPTION FACTOR AP-2

被引:510
|
作者
WILLIAMS, T
TJIAN, R
机构
关键词
ENHANCER FACTOR; DNA BINDING; DIMERIZATION; MAMMALIAN EXPRESSION; PROLINE-RICH ACTIVATOR; PALINDROMIC BINDING SITE;
D O I
10.1101/gad.5.4.670
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mammalian transcription factor AP-2 is a sequence-specific DNA-binding protein expressed in neural crest lineages and regulated by retinoic acid. Here we report a structure/function analysis of the DNA-binding and transcription activation properties of the AP-2 protein. DNA contact studies indicate that AP-2 binds as a dimer to a palindromic recognition sequence. Furthermore, cross-linking and immunoprecipitation data illustrate that AP-2 exists as a dimer even in the absence of DNA. Examination of cDNA mutants reveals that the sequences responsible for DNA binding are located in the carboxy-terminal half of the protein. In addition, a domain mediating dimerization forms an integral component of this DNA-binding structure. Expression of AP-2 in mammalian cells demonstrates that transcriptional activation requires an additional amino-terminal domain that contains an unusually high concentration of proline residues. This proline-rich activation domain also functions when attached to the heterologous DNA-binding region of the GAL4 protein. This study reveals that although AP-2 shares an underlying modular organization with other transcription factors, the regions of AP-2 involved in transcriptional activation and DNA binding/dimerization have novel sequence characteristics.
引用
收藏
页码:670 / 682
页数:13
相关论文
共 50 条
  • [1] Cloning and characterization of a novel mouse AP-2 transcription factor, Ap-2γ, with unique DNA binding and transactivation properties
    Zhao, F
    Satoda, M
    Licht, JD
    Hayashizaki, Y
    Gelb, BD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) : 40755 - 40760
  • [2] Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2
    Damberg, M
    Ekblom, J
    Oreland, L
    [J]. LIFE SCIENCES, 2000, 68 (06) : 669 - 678
  • [3] Identification of amino acid residues of transcription factor AP-2 involved in DNA binding
    García, MA
    Campillos, M
    Ogueta, S
    Valdivieso, F
    Vázquez, J
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2000, 301 (04) : 807 - 816
  • [4] DNA-BINDING PROPERTIES AND CHARACTERIZATION OF HUMAN TRANSCRIPTION FACTOR TFIIIC2
    BOULANGER, PA
    YOSHINAGA, SK
    BERK, AJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (31) : 15098 - 15105
  • [5] THE GENOMIC STRUCTURE OF THE HUMAN AP-2 TRANSCRIPTION FACTOR
    BAUER, R
    IMHOF, A
    PSCHERER, A
    KOPP, H
    MOSER, M
    SEEGERS, S
    KERSCHER, M
    TAINSKY, MA
    HOFSTAEDTER, F
    BUETTNER, R
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (08) : 1413 - 1420
  • [6] Different properties of three isoforms of transcription factor AP-2 in human keratinocytes
    Oyama, N
    Iwatsuki, K
    Homma, Y
    Kaneko, F
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 523 - 523
  • [7] Decrease in the AP-2 DNA-Binding Activity and in the Protein Expression of AP-2 α and AP-2 β in Frontal Cortex of Rats Treated with Lithium for 6 Weeks
    Jagadeesh S Rao
    Stanley I Rapoport
    Francesca Bosetti
    [J]. Neuropsychopharmacology, 2005, 30 : 2006 - 2013
  • [8] Identification and embryonic expression of a new AP-2 transcription factor, AP-2ε
    Wang, HV
    Vaupel, K
    Buettner, R
    Bosserhoff, AK
    Moser, M
    [J]. DEVELOPMENTAL DYNAMICS, 2004, 231 (01) : 128 - 135
  • [9] Regulation of the HMOX1 gene by the transcription factor AP-2δ with unique DNA binding site
    Sun, Liyun
    Zhao, Yuxia
    Gu, Shaohua
    Mao, Yumin
    Ji, Chaoneng
    Xin, Xiujuan
    [J]. MOLECULAR MEDICINE REPORTS, 2014, 10 (01) : 423 - 428
  • [10] Correction: Decrease in the AP-2 DNA-Binding Activity and in the Protein Expression of AP-2 a and AP-2 b in Frontal Cortex of Rats Treated with Lithium for 6 Weeks
    Jagadeesh S Rao
    Stanley I Rapoport
    Francesca Bosetti
    [J]. Neuropsychopharmacology, 2018, 43 : 456 - 456